Back to drug safety directory
TNF-α monoclonal antibody (autoimmune)Reviewed May 19, 2026

Adalimumab (Humira) and Ketamine Therapy | Tovani Health

Humira (Adalimumab)TNF-α monoclonal antibody (autoimmune)

Verdict at Tovani Health

Fully compatible; monoclonal antibodies don't interact via CYP.

Adalimumab and ketamine have no clinically significant interaction. Used for rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, ankylosing spondylitis, and other autoimmune conditions. Monoclonal antibodies are cleared by the reticuloendothelial system, not CYP enzymes, so they don't have the small-molecule interactions that complicate KAP planning for many drugs.

If you take Humira regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.

How Humira interacts with ketamine

Adalimumab is a fully human IgG1 monoclonal antibody that neutralizes TNF-α. Subcutaneous injection, usually every 1-2 weeks. No CYP, no small-molecule interaction surface.

What we do at intake

Continue as scheduled. Tell us your injection date and any infection history. Live vaccines and major infections are the usual considerations independent of KAP.

Bottom line

Adalimumab and ketamine have no clinically significant interaction. Used for rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, ankylosing spondylitis, and other autoimmune conditions. Monoclonal antibodies are cleared by the reticuloendothelial system, not CYP enzymes, so they don't have the small-molecule interactions that complicate KAP planning for many drugs.

Ready to find out if at-home ketamine fits your situation?

We’ll note that you’re on Humira (Adalimumab) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.

FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.

Clinically reviewed

Reviewed by Benjamin Soffer, DO on May 19, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.

This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.